Possible role of Toxoplasma gondii in brain cancer through modulation of host microRNAs

Infectious Agents and Cancer

Volumn 8, Issue 1, 2013, Pages

  Thirugnanam, Sivasakthivel ^a   Rout, Namita ^b   Gnanasekar, Munirathinam ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Brain cancer; miRNA; T. gondii

Indexed keywords

CASPASE 8; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MICRORNA; TRANSCRIPTION FACTOR E2F1;

APOPTOSIS; ARTICLE; BRAIN CANCER; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DISEASE ASSOCIATION; DOWN REGULATION; GLIOBLASTOMA; HOST CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; TOXOPLASMA GONDII; TOXOPLASMOSIS; TRANSCRIPTION REGULATION; UPREGULATION; VIRUS CELL INTERACTION;

EID: 84873447648     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-8-8     Document Type: Article

References (44)

1. Toxoplasmosis. Montoya JG, Liesenfeld O, Lancet 2004 363 1965 1976 10.1016/S0140-6736(04)16412-X 15194258
2. Toxoplasma gondii: from animals to humans. Tenter AM, Heckeroth AR, Weiss LM, Int J Parasitol 2000 30 1217 1258 10.1016/S0020-7519(00)00124-7 11113252
3. The development and biology of bradyzoites of toxoplasma gondii. Weiss LM, Kim K, Front Biosci 2000 5 391 D405 10.2741/Weiss 10762601
4. Stage differentiation of the protozoan parasite toxoplasma gondii. Bohne W, Holpert M, Gross U, Immunobiology 1999 201 248 254 10.1016/S0171-2985(99) 80065-5 10631574
5. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Dubey JP, Lindsay DS, Speer CA, Clin Microbiol Rev 1998 11 267 299 9564564
6. Host cell manipulation by the human pathogen toxoplasma gondii. Laliberté J, Carruthers VB, Cellular Mol Life Sci 2008 65 1900 1915 10.1007/s00018-008-7556-x
7. Toxoplasma gondii infection specifically increases the levels of key host microRNAs. Zeiner GM, Norman KL, Thomson JM, Hammond SM, Boothroyd JC, PLoS One 2010 5 8742 10.1371/journal.pone.0008742 20090903
8. Widespread changes in protein synthesis induced by microRNAs. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N, Nature 2008 455 58 63 10.1038/nature07228 18668040
9. Global and local architecture of the mammalian microRNA-transcription factor regulatory network. Shalgi R, Lieber D, Oren M, Pilpel Y, PLoS Comput Biol 2007 3 131 10.1371/journal.pcbi.0030131 17630826
10. Oncogenic role of microRNAs in brain tumors. Pang JC, Kwok WK, Chen Z, Ng HK, Acta Neuropathol 2009 117 599 611 10.1007/s00401-009-0525-0 19343354
11. The many roles of microRNAs in brain tumor biology. Turner JD, Williamson R, Almefty KK, Nakaji P, Porter R, Tse V, Kalani MY, Neurosurg Focus 2010 28 3 20568943
12. Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets. Wang D, Qiu C, Zhang H, Wang J, Cui Q, Yin Y, PLoS One 2010 5 9 13067 10.1371/journal.pone.0013067 20927335
13. Environmental risk factors for primary malignant brain tumors: a review. Wrensch M, Bondy ML, Wiencke J, Yost M, J Neurooncol 1993 17 47 64 10.1007/BF01054274 8120572
14. Tumours of the brain and presence of antibodies to toxoplasma gondii. Ryan P, Hurley SF, Johnson AM, Salzberg M, Lee MW, North JB, McNeil JJ, McMichael AJ, Int J Epidemiol 1993 22 412 419 10.1093/ije/22.3.412 8359956
15. Incidence of adult brain cancers is higher in countries where the protozoan parasite toxoplasma gondii is common. Thomas F, Lafferty KD, Brodeur J, Elguero E, Gauthier-Clerc M, Missé D, Biol Lett 2012 8 101 103 10.1098/rsbl.2011.0588 21795265
16. Brain cancer mortality rates increase with toxoplasma gondii seroprevalence in france. Vittecoq M, Elguero E, Lafferty KD, Roche B, Brodeur J, Gauthier-Clerc M, Missé D, Thomas F, Infection, Genetics Evol: J Mol Epidemiol Evolutionary Genetics in Infectious Diseases 2012 12 496 498 10.1016/j.meegid.2012.01.013
17. Intracellular protozoan parasites and apoptosis: diverse strategies to modulate parasite-host interactions. Lüder CG, Gross U, Lopes MF, Trends Parasitol 2001 17 480 486 10.1016/S1471-4922(01)02016-5 11587962
18. Microarray analysis reveals previously unknown changes in toxoplasma gondii-infected human cells. Blader IJ, Manger ID, Boothroyd JC, J Biol Chem 2001 276 24223 24231 10.1074/jbc.M100951200 11294868
19. Transcriptional profile of toxoplasma gondii-infected human fibroblasts as revealed by gene-array hybridization. Gail M, Gross U, Bohne W, Mol Genetics Genomics: MGG 2001 265 905 912 10.1007/s004380100487
20. CDNA microarray analysis of host-pathogen interactions in a porcine in vitro model for toxoplasma gondii infection. Okomo-Adhiambo M, Beattie C, Rink A, Infect Immun 2006 74 4254 4265 10.1128/IAI.00386-05 16790800
21. Mechanisms underlying the manipulation of host apoptotic pathways by toxoplasma gondii. Sinai AP, Payne TM, Carmen JC, Hardi L, Watson SJ, Molestina RE, Int J Parasitol 2004 34 381 391 10.1016/j.ijpara.2003.11.009 15003498
22. Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. Nash PB, Purner MB, Leon RP, Clarke P, Duke RC, Curiel TJ, J Immunol (Baltimore, Md: 1950) 1998 160 1824 1830
23. Toxoplasma gondii inhibits Fas/CD95-triggered cell death by inducing aberrant processing and degradation of caspase 8. Vutova P, Wirth M, Hippe D, Gross U, Schulze-Osthoff K, Schmitz I, Lüder CGK, Cell Microbiol 2007 9 1556 1570 10.1111/j.1462-5822.2007.00893.x 17298390
24. Toxoplasma gondii infection confers resistance against BimS-induced apoptosis by preventing the activation and mitochondrial targeting of pro-apoptotic Bax. Hippe D, Weber A, Zhou L, Chang DC, Häcker G, Lüder CGK, J Cell Sci 2009 122 3511 3521 10.1242/jcs.050963 19737817
25. Toxoplasma gondii inhibits ultraviolet light-induced apoptosis through multiple interactions with the mitochondrion-dependent programmed cell death pathway. Carmen JC, Hardi L, Sinai AP, Cell Microbiol 2006 8 301 315 10.1111/j.1462-5822.2005.00622.x 16441440
26. Inhibition of host cell apoptosis by toxoplasma gondii is accompanied by reduced activation of the caspase cascade and alterations of poly(ADP-ribose) polymerase expression. Goebel S, Gross U, Luder CG, J Cell Sci 2001 114 3495 3505 11682609
27. Activation of NF-kappaB by toxoplasma gondii correlates with increased expression of antiapoptotic genes and localization of phosphorylated IkappaB to the parasitophorous vacuole membrane. Molestina RE, Payne TM, Coppens I, Sinai AP, J Cell Sci 2003 116 4359 4371 10.1242/jcs.00683 12966164
28. Toxoplasma gondii inhibits apoptosis in infected cells by caspase inactivation and NF-kappaB activation. Kim J-Y, Ahn M-H, Jun H-S, Jung J-W, Ryu J-S, Min D-Y, Yonsei Med J 2006 47 862 869 10.3349/ymj.2006.47.6.862 17191317
29. Toxoplasma gondii triggers Gi-dependent PI 3-kinase signaling required for inhibition of host cell apoptosis. Kim L, Denkers EY, J Cell Sci 2006 119 2119 2126 10.1242/jcs.02934 16638808
30. Use of two novel approaches to discriminate between closely related host microRNAs that are manipulated by toxoplasma gondii during infection. Zeiner GM, Boothroyd JC, RNA 2010 16 1268 1274 10.1261/rna.2069310 20423977
31. De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures. Ernst A, Campos B, Meier J, Devens F, Liesenberg F, Wolter M, Reifenberger G, Herold-Mende C, Lichter P, Radlwimmer B, Oncogene 2010 29 3411 3422 10.1038/onc.2010.83 20305691
32. The miR-17 92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Uziel T, Karginov FV, Xie S, Parker JS, Wang Y-D, Gajjar A, He L, Ellison D, Gilbertson RJ, Hannon G, Roussel MF, Proc Natl Acad Sci U S A 2009 106 2812 2817 10.1073/pnas.0809579106 19196975
33. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Northcott PA, Fernandez-L A, Hagan JP, Ellison DW, Grajkowska W, Gillespie Y, Grundy R, Van Meter T, Rutka JT, Croce CM, et al. Cancer Res 2009 69 3249 3255 10.1158/0008-5472.CAN-08-4710 19351822
34. MicroRNA involvement in brain tumors: from bench to bedside. Nicoloso MS, Calin GA, Brain Pathol 2008 18 122 129 10.1111/j.1750-3639.2007.00119.x 18226107
35. Extensive modulation of a set of microRNAs in primary glioblastoma. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM, Farace MG, Biochem Biophys Res Commun 2005 334 1351 1358 10.1016/j.bbrc.2005.07.030 16039986
36. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Chan JA, Krichevsky AM, Kosik KS, Cancer Res 2005 65 6029 6033 10.1158/0008-5472.CAN- 05-0137 16024602
37. MicroRNA-21 suppression impedes medulloblastoma cell migration. Grunder E, D'Ambrosio R, Fiaschetti G, Abela L, Arcaro A, Zuzak T, Ohgaki H, Lv SQ, Shalaby T, Grotzer M, Eur J Cancer 2011 47 2479 2490 10.1016/j.ejca.2011.06.041 21775132
38. MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. Chen Y, Liu W, Chao T, Zhang Y, Yan X, Gong Y, Qiang B, Yuan J, Sun M, Peng X, Cancer Lett 2008 272 197 205 10.1016/j.canlet.2008.06.034 19013014
39. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. Bottoni A, Zatelli MC, Ferracin M, Tagliati F, Piccin D, Vignali C, Calin GA, Negrini M, Croce CM, Degli Uberti EC, J Cell Physiol 2007 210 370 377 10.1002/jcp.20832 17111382
40. A complex small RNA repertoire is generated by a plant/fungal-like machinery and effected by a metazoan-like argonaute in the single-cell human parasite toxoplasma gondii. Braun L, Cannella D, Ortet P, Barakat M, Sautel CF, Kieffer S, Garin J, Bastien O, Voinnet O, Hakimi M-A, PLoS pathogens 2010 6 1000920 10.1371/journal.ppat.1000920 20523899
41. Virus-encoded microRNAs. Grundhoff A, Sullivan CS, Virology 2011 411 325 343 10.1016/j.virol.2011.01.002 21277611
42. MicroRNA profiling: approaches and considerations. Pritchard CC, Cheng HH, Tewari M, Nat Rev Genet 2012 13 358 369 22510765
43. Small-animal molecular imaging methods. de Kemp RA, Epstein FH, Catana C, Tsui BM, Ritman EL, J Nucl Med 2010 51 Suppl 1 18S 32S 20457793
44. Molecular brain imaging in the multimodality era. Price JC, J Cereb Blood Flow Metab 2012 32 1377 1392 10.1038/jcbfm.2012.29 22434068